Christopher Posner - President & Chief Executive Officer @ Cara Therapeutics

Overview

Number of Current Board & Advisor Roles

CB Rank (Person)

Christopher Posner is the President and CEO of Cara Therapeutics. He attended Duke University - The Fuqua School of Business.

Number of Current Jobs

is the

President & Chief Executive Officer

Number of Current Board & Advisor Roles

is the

Member, Board of Directors

Hub Name	CB Rank (Hub)
Connecticut Innovations Portfolio Companies	28,684
Rho Capital Partners Portfolio Companies	72,208
Alta Partners Portfolio Companies	70,198
Closed Northeastern US Health Care Companies	21,784
Rho Ventures Portfolio Companies	77,162
Mitsubishi Corporation Portfolio Companies	85,391
MVM Life Science Partners Portfolio Companies	75,497
Closed United States Therapeutics Companies	41,438
Closed Northeastern US Biotechnology Companies	31,256

There is no recent news or activity for this profile.